ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 858,83
-0,22%
Dow Jones
42 113,07
0,29%
DAX
22 390,84
-0,64%
Brent Oil
74,865
0,60%
Bitcoin
86 241,54
1,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sunesis Pharmaceuticals Inc (SNSS)

  7. Sunesis Pharmaceuticals Inc (SNSS) Actualités

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateHeureSourceTitreSymboleSociété
10/06/202300h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/05/202322h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/05/202322h53Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202322h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202322h09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/03/202322h14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/02/202312h03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/01/202323h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/11/202222h38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
20/09/202200h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/202222h58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/06/202222h37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/12/202112h08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/02/202122h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
15/01/202112h24Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/01/202123h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
13/01/202112h03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/11/202022h05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/202013h00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/10/202013h00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/202013h00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/09/202018h48GlobeNewswire Inc.Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock SplitNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/08/202022h05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/08/202013h00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Hi...NASDAQ:SNSSSunesis Pharmaceuticals Inc
31/07/202000h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
29/07/202015h05GlobeNewswire Inc.Sunesis Announces Pricing of $12 Million Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
28/07/202022h07GlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/07/202022h01GlobeNewswire Inc.Sunesis Pharmaceuticals Provides Corporate UpdateNASDAQ:SNSSSunesis Pharmaceuticals Inc
23/06/202013h30GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib ProgramNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/202022h05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS

Dernières Valeurs Consultées

USOTC
NTDOY
Nintendo (PK)
NASDAQ
SGHT
Sight Sciences
LSE
0Q4D
Tatra Banka As
TSXV
KEN
Kenadyr Metals
LBNK
FKXUSDT
Knoxstertoken
KRKN
BALUSD
Balancer
DOWI
DWCGAM
DJ US Gambling Total Sto...
AQSE
SAV.GB
Savannah Resources
BOV
ALUP3
ALUPAR ON
NYSE
SITC
SITE Centers
AMEX
CURE
Direxion Daily Healthcar...
HITB
PNGUSDT
Pangolin
BIT
FHLVOL
Vontobel
FX
ZARUYU
ZAR vs UYU
BIT
UI339C
Unicredit Bank
EU
NK
Imerys
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces